|
Please
download and print the PDF file below:
|
|
|
|
Kandace J. Landreneau, PhD, RN, CCTC
|
Kandace J. Landreneau, PhD, RN, CCTC, is
Postdoctoral Scholar, University of California, San
Francisco, CA. She is a member of the Northern
California Chapter of ANNA.
|
|
Peggy Ward-Smith, PhD, RN
|
Peggy Ward-Smith, PhD, RN, is Associate
Professor, University of Missouri, Kansas City, MO.
|
Purpose: The purposes of this pilot study were to determine which replacement therapy group would
be most appropriate for exploring the concept of choice and to refine the research question.
Methods: This exploratory, descriptive study used a phenomenological method.
Results: Four themes were derived: (1) uncertainty of long-term health, (2) lack of choice, (3) no memory
of making a choice, and (4) lack of information about renal replacement therapies.
Conclusions: No participant remembered actually making a choice regarding their renal replacement
therapies.
|
|
CE
RELATED INFORMATION |
|
This
offering for 1.4 contact
hours is being provided by
the
American
Nephrology Nurses Association
(ANNA), which
is accredited as a provider
and approver of continuing
education in nursing by
the American Nurses
Credentialing Center-Commission
on Accreditation (ANCCCOA).
This educational activity
is approved by most states
and specialty organizations
that recognize the ANCC-COA
accreditation process. ANNA
is an approved provider of
continuing education in nursing
by the California Board of
Registered Nursing, BRN Provider
No. 00910; and the Kansas
State Board of Nursing, Provider
No. LT0148-0738. This offering
is accepted for RN and LPN
relicensure in Kansas
|
|
Goal:
To explore the concept of choice perceived by patients receiving renal replacement
therapies.
Objectives:
1.Summarize the perceptions of queried patients about their perception of
having a choice of renal replacement therapies.
2.Analyze the findings of a study of patients receiving renal replacement
therapies and their involvement in the choice of that therapy.
3. Recommend future research to determine patients involvement in the choice
of renal replacement therapy to be used.
|
AUTHOR DISCLOSURE
STATEMENT |
Kandace J. Landreneau has
no conflicts of interest to disclose.
Peggy Ward-Smith has
no conflicts of interest to disclose.
|
ANNA and HDCN CE POLICY STATEMENTS |
The CE policy and disclosure statements of the American Nephrology
Nurses' Association are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are listed on
this page. |